IPA
vs
DHR
IPA
DHR
Over the past 12 months, IPA has underperformed DHR, delivering a return of 0% compared to the DHR's +1% growth.
Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
Smart Verdict
AI-Powered
Let AI Decide.
IPA
DHR
Valuation Comparison
| Company | Last Price | Intrinsic Value | DCF Value | Relative Value | Wall St Target | ||
|---|---|---|---|---|---|---|---|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
6.5
CAD
|
|||||
|
Danaher Corp
NYSE:DHR
|
226.39
USD
|
|||||
Compare the stock's valuation with its competitors.
Growth Comparison
Growth Over Time
IPA, DHR
Compare company's financials with its competitors.
| Company | LTM | Historical Growth | Growth Streak | % Positive Years | Max Drawdown | Volatility | Forecasted Growth | |||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 10 Years | 1 Year | 3 Years | ||||||||
|
|
Immunoprecise Antibodies Ltd
Revenue
|
|||||||||||
|
|
Danaher Corp
Revenue
|
|||||||||||
All metrics are calculated based on data from the last 10 years.
Compare company's financials with its competitors.
Profitability Comparison
Free Cash Flow
IPA, DHR
Compare company's free cash flow with its competitors.
| Company | LTM | Average | Historical Growth | FCF Margin | Conversion | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| 3 Years | 5 Years | 3 Years | 5 Years | 10 Years | ||||||
|
|
Immunoprecise Antibodies Ltd
XTSX:IPA
|
|||||||||
|
|
Danaher Corp
NYSE:DHR
|
|||||||||
Compare company's free cash flow with its competitors.
Operating Margin
| LTM | 3Y Avg | 5Y Avg | 10Y Avg | ||
|---|---|---|---|---|---|
|
|
Immunoprecise Antibodies Ltd | ||||
|
|
Danaher Corp | ||||
Solvency Comparison
Compare company's equity waterfall with its competitors.
Stocks Performance
Stocks Performance
IPA, DHR
Performance By Year
IPA, DHR
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
